glp-1 and gip Biology of Incretins: GLP-1 receptor agonists are increasingly

Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications increasingly prescribed in the UK for managing type 2 diabetes mellitus and, more recently, for weight management in specific patient populations

It does this by: Stimulating your pancreas to release insulin (which lowers blood sugar) Slowing down how fast your stomach empties (so you feel full longer) Reducing the release of another hormone called glucagon (which raises blood sugar) Acting on the brain to decrease appetite In people with type 2 diabetes or metabolic challenges, the body either doesnt make enough GLP-1 or doesnt respond to it properly

Combining ColonBroom with healthy habits is another best practice

V: Waarom 99% zuiverheid